The effect of body mass index on the safety of bosutinib in patients with chronic leukemia: A post hoc pooled data analysis

Affiliations

• ¹ Department of Hematology, Hemostasis, Oncology and Stem Cell Translation, Comprehensive Cancer Center Hannover (Claudia von Schilling-Center), Medical School Hannover (MHH), Hannover, Germany; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany. Electronic address: [email protected].
• ² University of Milano-Bicocca, Monza, Italy.
• ³ Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Germany.
• ⁴ John Hopkins University School of Medicine, Baltimore, MD, USA.
• ⁵ Pfizer Ltd., London, UK.
• ⁶ Pfizer Ltd., Berlin, Germany.
• ⁷ Pfizer (China) R&D Co., Ltd., Shanghai, China.
• ⁸ Imperial College London, London, UK.